Dier Mardi
Insider CIK 1574591 · MDGL SVP and CFO · PTLA Senior VP and CFO · ADMS Director · RARE CFO & Executive Vice President · PRLD Director · ORIC Director · SLRN CFO and CBO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 116 | $432.56 | $50.2K | 12,850 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 120 | $430.90 | $51.7K | 12,966 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 40 | $429.58 | $17.2K | 13,086 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 160 | $429.00 | $68.6K | 13,126 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 80 | $427.85 | $34.2K | 13,286 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 420 | $426.86 | $179.3K | 13,366 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 40 | $425.08 | $17.0K | 13,786 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 646 | $431.94 | $279.0K | 13,826 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 40 | $437.65 | $17.5K | 12,490 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 80 | $436.69 | $34.9K | 12,530 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 80 | $435.32 | $34.8K | 12,610 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-06 | 2026-03-06 | 160 | $434.20 | $69.5K | 12,690 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2026-03-04 | 2026-03-06 | 6,519 | — | $0 | 6,519 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2026-03-04 | 2026-03-06 | 5,215 | — | $0 | 14,472 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-03-02 | 2026-03-02 | 1,183 | $427.21 | $505.4K | 9,257 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-12-02 | 2025-12-03 | 4,173 | — | $0 | 9,180 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 120 | $574.95 | $69.0K | 12,692 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-12-02 | 2025-12-03 | 4,173 | $251.63 | $1.05M | 14,613 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 354 | $573.02 | $202.8K | 13,529 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 410 | $571.99 | $234.5K | 13,883 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 320 | $570.39 | $182.5K | 14,293 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 240 | $576.15 | $138.3K | 12,452 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 320 | $577.81 | $184.9K | 12,132 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 258 | $578.83 | $149.3K | 11,874 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 480 | $579.85 | $278.3K | 11,394 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 240 | $585.44 | $140.5K | 11,154 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 240 | $587.85 | $141.1K | 10,914 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 160 | $589.65 | $94.3K | 10,754 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 160 | $590.37 | $94.5K | 10,594 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 74 | $595.20 | $44.0K | 10,520 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 80 | $596.19 | $47.7K | 10,440 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-02 | 2025-12-03 | 717 | $574.00 | $411.6K | 12,812 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2025-06-12 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-10 | 2025-03-12 | 258 | $323.04 | $83.3K | 10,440 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2025-03-05 | 2025-03-07 | 6,374 | — | $0 | 6,374 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2025-03-05 | 2025-03-07 | 3,784 | — | $0 | 10,698 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 774 | $323.54 | $250.4K | 6,914 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 1,187 | $325.89 | $386.8K | 7,688 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-06 | 35,000 | — | $0 | 35,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2024-06-14 | 2024-06-18 | 23,500 | — | $0 | 23,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 25,600 | — | $0 | 25,600 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2023-06-16 | 2023-06-21 | 23,500 | — | $0 | 23,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2023-06-14 | 2023-06-15 | 20,500 | — | $0 | 20,500 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 85,226 | — | $0 | 85,226 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 85,226 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 673,621 | — | $0 | 673,621 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 673,621 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | P Buy | 2023-05-09 | 2023-05-11 | 875 | $18.00 | $15.8K | 875 | SEC↗ |
| SLRN ACELYRIN, Inc. | P Buy | 2023-05-09 | 2023-05-11 | 875 | $18.00 | $15.8K | 875 | SEC↗ |
| SLRN ACELYRIN, Inc. | P Buy | 2023-05-09 | 2023-05-11 | 5,556 | $18.00 | $100.0K | 5,556 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award deriv | 2023-05-04 | 2023-05-04 | 85,226 | — | $0 | 85,226 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2022-10-14 | 2022-10-17 | 1,629 | $40.16 | $65.4K | 66,695 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2022-10-12 | 2022-10-14 | 3,484 | $38.22 | $133.2K | 68,324 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2022-09-16 | 2022-09-19 | 20,000 | — | $0 | 71,808 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-06-17 | 2022-06-17 | 53,700 | — | $0 | 53,700 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2022-06-17 | 2022-06-22 | 34,300 | — | $0 | 34,300 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2022-03-03 | 2022-03-03 | 420 | $64.55 | $27.1K | 51,808 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2022-03-01 | 2022-03-03 | 24,900 | — | $0 | 24,900 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2022-03-01 | 2022-03-03 | 14,000 | — | $0 | 52,228 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2022-03-01 | 2022-03-03 | 534 | $66.62 | $35.6K | 38,228 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-10-14 | 2021-10-14 | 3,261 | $81.16 | $264.7K | 38,762 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-10-12 | 2021-10-14 | 3,477 | $82.79 | $287.9K | 42,023 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2021-06-18 | 2021-06-22 | 23,344 | — | $0 | 23,344 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 16,625 | — | $0 | 16,625 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2021-06-02 | 2021-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2021-06-02 | 2021-06-04 | 5,000 | — | $0 | 10,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2021-03-01 | 2021-03-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-03-01 | 2021-03-03 | 5,500 | — | $0 | 45,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2020-10-12 | 2020-10-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-10-12 | 2020-10-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2020-09-29 | 2020-09-29 | 10,000 | $19.00 | $190.0K | 10,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2020-09-24 | 2020-09-28 | 3,458 | — | $0 | 3,458 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 32,500 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 24,375 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 48,750 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 32,291 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 371,545 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 65,000 | $5.21 | $338.6K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2020-07-02 | 2020-07-02 | 39,563 | $18.00 | $712.1K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2020-07-02 | 2020-07-02 | 10 | $18.00 | $180 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2020-06-18 | 2020-07-02 | 10 | $8.36 | $84 | 10 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2020-06-03 | 2020-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2020-06-03 | 2020-06-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2020-04-23 | 2020-04-27 | 33,250 | — | $0 | 33,250 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2020-03-02 | 2020-03-03 | 4,543 | $9.68 | $44.0K | 78,229 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2020-02-24 | 2020-02-26 | 73,125 | — | $0 | 73,125 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2020-02-03 | 2020-02-04 | 3,435 | $12.89 | $44.3K | 81,533 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2020-01-31 | 2020-02-04 | 65,000 | — | $0 | 65,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2020-01-31 | 2020-02-04 | 16,250 | — | $0 | 84,968 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2020-01-14 | 2020-01-14 | 1,277 | $13.80 | $17.6K | 68,718 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2020-01-12 | 2020-01-14 | 2,125 | — | $0 | 69,995 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2019-06-05 | 2019-06-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2019-05-20 | 2019-05-21 | 3,022 | $28.69 | $86.7K | 69,570 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2019-05-19 | 2019-05-21 | 5,859 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2019-05-19 | 2019-05-21 | 5,859 | — | $0 | 72,592 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2019-04-04 | 2019-04-08 | 40,486 | $37.39 | $1.51M | 66,733 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2019-03-04 | 2019-03-05 | 9,667 | $33.41 | $323.0K | 107,219 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2019-01-31 | 2019-02-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2019-01-31 | 2019-02-04 | 18,750 | — | $0 | 116,682 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2019-01-15 | 2019-01-15 | 868 | $24.25 | $21.0K | 97,932 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2019-01-12 | 2019-01-15 | 2,125 | — | $0 | 98,800 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2018-09-04 | 2018-09-05 | 8,884 | $29.18 | $259.2K | 98,800 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2018-08-31 | 2018-09-05 | 17,500 | — | $0 | 107,684 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2018-08-23 | 2018-08-28 | 8,794 | $26.05 | $229.1K | 107,477 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2018-07-28 | 2018-08-28 | 17,500 | — | $0 | 116,271 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2018-06-06 | 2018-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2018-05-22 | 2018-05-24 | 2,514 | $40.82 | $102.6K | 116,271 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2018-05-22 | 2018-05-24 | 5,859 | — | $0 | 118,785 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2018-03-08 | 2018-03-12 | 2,009 | $39.16 | $78.7K | 61,442 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2018-03-08 | 2018-03-12 | 10,465 | $38.69 | $404.9K | 63,451 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2018-03-02 | 2018-03-06 | 6,735 | $32.53 | $219.1K | 31,040 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2018-01-31 | 2018-02-02 | 42,500 | — | $0 | 42,500 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2018-01-31 | 2018-02-02 | 10,625 | — | $0 | 10,625 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2017-10-10 | 2017-10-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2017-08-16 | 2017-08-18 | 3,635 | $54.86 | $199.4K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2017-07-11 | 2017-07-13 | 23,350 | — | $0 | 35,390 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2017-07-11 | 2017-07-13 | 23,350 | $60.00 | $1.40M | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2017-07-11 | 2017-07-13 | 23,350 | $25.08 | $585.6K | 23,350 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2017-06-27 | 2017-06-28 | 6,885 | — | $0 | 57,177 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2017-06-27 | 2017-06-28 | 60,937 | — | $0 | 6,250 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2017-06-27 | 2017-06-28 | 16,029 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2017-06-27 | 2017-06-28 | 1,191 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2017-06-27 | 2017-06-28 | 8,350 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2017-06-27 | 2017-06-28 | 16,029 | $9.50 | $152.3K | 16,029 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2017-06-27 | 2017-06-28 | 1,191 | $7.00 | $8.3K | 1,191 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2017-06-27 | 2017-06-28 | 8,350 | $7.00 | $58.5K | 8,350 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2017-06-27 | 2017-06-28 | 60,937 | $22.06 | $1.34M | 60,937 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2017-06-27 | 2017-06-28 | 6,885 | $25.08 | $172.7K | 6,885 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2017-06-27 | 2017-06-28 | 42,421 | $54.94 | $2.33M | 50,971 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2017-06-27 | 2017-06-28 | 46,478 | $55.83 | $2.59M | 4,493 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2017-06-27 | 2017-06-28 | 4,493 | $56.61 | $254.3K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2017-03-15 | 2017-03-16 | 4,300 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2017-03-15 | 2017-03-16 | 5,935 | — | $0 | 8,350 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2017-03-15 | 2017-03-16 | 4,300 | $8.50 | $36.5K | 4,300 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2017-03-15 | 2017-03-16 | 5,935 | $7.00 | $41.5K | 5,935 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2017-03-15 | 2017-03-16 | 10,235 | $40.02 | $409.6K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2017-03-02 | 2017-03-03 | 5,334 | $38.61 | $205.9K | 50,767 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2017-01-30 | 2017-02-01 | 62,500 | — | $0 | 62,500 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2017-01-30 | 2017-02-01 | 15,625 | — | $0 | 15,625 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2017-01-30 | 2017-02-01 | 15,625 | — | $0 | 15,625 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2016-08-01 | 2016-08-01 | 15,152 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2016-08-01 | 2016-08-01 | 15,152 | $3.30 | $50.0K | 15,152 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2016-05-01 | 2016-05-03 | 32,500 | — | $0 | 32,500 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2016-05-01 | 2016-05-03 | 16,250 | — | $0 | 16,250 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | F Tax w/h | 2016-03-02 | 2016-03-04 | 1,524 | $31.75 | $48.4K | 10,476 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2016-01-27 | 2016-01-29 | 55,000 | — | $0 | 55,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2016-01-27 | 2016-01-29 | 13,750 | — | $0 | 13,750 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2016-01-27 | 2016-01-29 | 13,750 | — | $0 | 13,750 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-09-18 | 2015-09-21 | 2,934 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-09-18 | 2015-09-21 | 5,000 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-09-18 | 2015-09-21 | 978 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-09-18 | 2015-09-21 | 978 | $5.10 | $5.0K | 3,912 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-09-18 | 2015-09-21 | 2,934 | $5.10 | $15.0K | 2,934 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-09-18 | 2015-09-21 | 5,000 | $9.00 | $45.0K | 8,912 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-09-18 | 2015-09-21 | 8,912 | $55.00 | $490.2K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-06-08 | 2015-06-09 | 12,195 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-06-08 | 2015-06-09 | 3,924 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-06-08 | 2015-06-09 | 3,924 | $5.00 | $19.6K | 3,924 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-06-08 | 2015-06-09 | 12,195 | $4.10 | $50.0K | 16,119 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-06-08 | 2015-06-09 | 16,119 | $43.00 | $693.1K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-05-27 | 2015-05-27 | 6,076 | — | $0 | 3,924 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-05-27 | 2015-05-27 | 6,076 | $5.00 | $30.4K | 6,076 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-05-27 | 2015-05-27 | 6,076 | $41.00 | $249.1K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-05-12 | 2015-05-12 | 13,290 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-05-12 | 2015-05-12 | 13,290 | $9.50 | $126.3K | 13,290 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-05-12 | 2015-05-12 | 13,290 | $37.88 | $503.4K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-05-11 | 2015-05-12 | 9,151 | — | $0 | 13,290 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-05-11 | 2015-05-12 | 4,523 | — | $0 | 1,191 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-05-11 | 2015-05-12 | 9,151 | $9.50 | $86.9K | 13,674 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-05-11 | 2015-05-12 | 4,523 | $7.00 | $31.7K | 4,523 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-05-11 | 2015-05-12 | 13,674 | $38.21 | $522.5K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-02-23 | 2015-02-23 | 3,454 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-02-23 | 2015-02-23 | 2,238 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-02-23 | 2015-02-23 | 3,454 | $4.10 | $14.2K | 5,692 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-02-23 | 2015-02-23 | 5,692 | $39.95 | $227.4K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-02-23 | 2015-02-23 | 2,238 | $5.00 | $11.2K | 2,238 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2015-01-27 | 2015-01-29 | 56,000 | — | $0 | 56,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2015-01-27 | 2015-01-29 | 35,000 | — | $0 | 35,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2015-01-27 | 2015-01-29 | 12,000 | — | $0 | 12,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2014-11-25 | 2014-11-25 | 1,118 | $28.23 | $31.6K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2014-08-25 | 2014-08-25 | 1,504 | $25.72 | $38.7K | 4,614 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2014-08-25 | 2014-08-25 | 3,496 | $26.50 | $92.6K | 1,118 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2014-07-25 | 2014-07-25 | 5,000 | $24.11 | $120.5K | 6,118 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2014-06-25 | 2014-06-25 | 5,000 | $28.52 | $142.6K | 11,118 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2014-06-18 | 2014-06-19 | 3,706 | $29.95 | $111.0K | 16,118 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2014-05-29 | 2014-05-29 | 5,000 | $23.00 | $115.0K | 19,824 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2014-04-25 | 2014-04-28 | 100 | $24.75 | $2.5K | 24,824 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2014-04-25 | 2014-04-28 | 4,900 | $24.13 | $118.2K | 24,924 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2014-03-26 | 2014-03-27 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2014-03-25 | 2014-03-27 | 5,000 | $25.69 | $128.4K | 29,824 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2013-11-06 | 2013-11-07 | 75,000 | — | $0 | 75,000 | SEC↗ |